Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer
NCT01207895
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
DEVICE:
PET imaging with [18F]-FLT
DRUG:
[18F]-fluorodeoxythymidine
Sponsor
Vanderbilt-Ingram Cancer Center